| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |